Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-10-24
2006-10-24
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S230800, C514S241000, C514S254020, C514S255050, C514S256000, C514S269000, C514S274000, C514S338000, C514S369000, C514S379000, C540S524000, C544S137000, C544S220000, C544S310000, C544S331000, C544S368000, C544S405000, C546S272100, C548S183000, C548S241000
Reexamination Certificate
active
07125865
ABSTRACT:
The present invention relates to novel LXR ligands of Formula I and the pharmaceutically acceptable salts, esters and tautomers thereof, which are useful in the treatment of dyslipidemic conditions, particularly depressed levels of HDL cholesterol.
REFERENCES:
patent: 6008237 (1999-12-01), Sahoo et al.
patent: 6908934 (2005-06-01), Adams et al.
patent: 2002/0173663 (2002-11-01), Liu et al.
patent: 2003/0086923 (2003-05-01), Sparrow et al.
patent: 2003/0125357 (2003-07-01), Adams et al.
patent: WO 01/41704 (2001-06-01), None
patent: WO 03/045382 (2003-06-01), None
patent: WO 03/053352 (2003-07-01), None
Menke, et al., Endocrinology, “A Novel Liver X Receptor Agonist Establishes Species Differences in the Regulation of Cholesterol 7alpha-Hydroxylase (CYP7a)”, 143(7) pp. 2548-2558, Jul. 2002.
Adams Alan D.
Cheng Yuan
Green Ahren I.
Gutteridge Clare E.
Huang Shaei Y.
Kifle Bruck
Merck & Co. , Inc.
Quagliato Carol S.
Winckur Melvin
LandOfFree
Therapeutic compounds for treating dyslipidemic conditions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic compounds for treating dyslipidemic conditions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic compounds for treating dyslipidemic conditions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3671685